Key Financial Data Of Group

Astellas Pharma Inc. - Filing #7723038

Concept As at
2018-06-30
2018-04-01 to
2018-06-30
2017-04-01 to
2018-03-31
As at
2018-03-31
As at
2017-06-30
2017-04-01 to
2017-06-30
Key financial data of group
Business results of group
Revenue
329,085,000,000 JPY
1,300,316,000,000 JPY
322,571,000,000 JPY
Profit (loss) before tax
64,495,000,000 JPY
218,113,000,000 JPY
48,471,000,000 JPY
Profit (loss), attributable to owners of parent
54,559,000,000 JPY
164,679,000,000 JPY
42,468,000,000 JPY
Comprehensive income, attributable to owners of parent
70,861,000,000 JPY
198,539,000,000 JPY
83,520,000,000 JPY
Equity attributable to owners of parent
1,275,921,000,000 JPY
1,268,289,000,000 JPY
1,319,652,000,000 JPY
Total assets
1,866,551,000,000 JPY
1,858,205,000,000 JPY
1,901,237,000,000 JPY
Basic earnings (loss) per share
27.68
81.11
20.57
Diluted earnings (loss) per share
27.65
81.02
20.54
Ratio of owners' equity to gross assets
0.684 xbrli:pure
0.683 xbrli:pure
0.694 xbrli:pure
Cash flows from (used in) operating activities
37,179,000,000 JPY
312,614,000,000 JPY
59,492,000,000 JPY
Cash flows from (used in) investing activities
2,446,000,000 JPY
-121,799,000,000 JPY
-56,026,000,000 JPY
Cash flows from (used in) financing activities
-63,289,000,000 JPY
-203,429,000,000 JPY
-36,154,000,000 JPY
Cash and cash equivalents
309,741,000,000 JPY
331,731,000,000 JPY
314,417,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.